Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

Filter your results:

Types

Topics

10 Results Found

Public

Costs of Caring

This Costs of Caring report provides a data-driven assessment of the financial realities faced by hospitals and health systems, and underscores why sustainable affordability solutions must address the structural drivers of cost growth rather than focusing narrowly on hospital prices alone.
Finance & Budgeting, Cost Management, Workforce, Nurses, Drug Prices, Workforce Supply and Demand, Advocacy & Public Policy, Telling the Hospital Story, Tariffs

Executive Summary: Tariffs and Their Impact on the U.S. Health Care Supply Chain

The U.S. health care system relies heavily on a global supply chain for pharmaceuticals and medical devices. This global interdependence makes the health care sector particularly vulnerable to tariff-related disruptions.
Legislation and Legislative Advocacy, Financial Management, Shipping and Receiving, Tariffs
Member

AHA Urges Administration to Grant Exceptions for Current and Proposed Tariffs for Medications and Medical Supplies

The AHA late yesterday told the administration that its current and proposed tariffs on Canada, Mexico and China may jeopardize the availability of vital medications and essential health care devices.
Medication management, Supply chain management, Medical Device Purchasing, Tariffs
Public

Tariff Implications for American Health Care

A series of tariffs recently implemented could have significant implications for health care.
Supply chain management, Tariffs
Public

AHA Urges Administration to Grant Exceptions for Tariffs for Medications and Medical Supplies

The AHA asks President Trump to consider granting exceptions to the current and proposed tariffs for medical devices and pharmaceuticals made in Mexico, Canada and China that are essential to the provision of safe, effective care in America's hospitals, clinics, and other settings.
Supply chain management, Medical Device Purchasing, Drug Prices, Drug shortages, Tariffs
Public

AHA Comments on Commerce Department Investigation of Pharmaceutical Imports

AHA comments on the Department of Commerce’s request for public comment on its Section 232 national security investigation on pharmaceutical and pharmaceutical ingredient imports.
Supply chain management, Tariffs
Public

AHA Responds to Commerce Department Investigation of Critical Minerals

AHA comments on the Department of Commerce’s request for public comment on its Section 232 national security investigation on processed critical minerals and derivative products.
Medical Device Purchasing, Medical Device Technology, Supply chain management, Tariffs
Member

Trump Administration Unveils New Tariff Plan

The White House April 2 issued an executive order implementing a comprehensive new tariff plan.
Advocacy & Public Policy, Supply chain management, Tariffs
Public

Chair File: Leadership Dialogue — Tariffs and Health Care with Brian Pomper and Akin Demehin

In this Leadership Dialogue, I am joined by Brian Pomper, a partner specializing in international trade policy at Akin Gump Strauss Hauer & Feld, and Akin Demehin, vice president of quality and safety policy at the AHA. We discuss tariffs and their potential implications on the health care supply chain.
Supply chain management, Leadership Dialogue, Tariffs
Public

Tariffs, Trade and the Health Care Supply Chain: What Leaders Need to Know

Tina Freese Decker talks with Brian Pomper about the past and present state of U.S. tariff policy, how tariffs could impact hospital and health system operations, and ways health care leaders can engage as policy advocates.
Supply chain management, Leadership Dialogue, Tariffs